Evidence map›Paper›PMID 39564756›Full record

ArticleCNS neuroscience & therapeutics2024

Lycium barbarum Extract Enhanced Neuroplasticity and Functional Recovery in 5xFAD Mice via Modulating Microglial Status of the Central Nervous System.

Zhongqing Sun, Jinfeng Liu, Zihang Chen, Kwok-Fai So, Yong Hu, Kin Chiu

Abstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhongqing SunDepartment of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.ORCID 0009-0000-5235-5880
Jinfeng LiuDepartment of Ophthalmology, School of Clinical Medicine, The University of Hong Kong, Hong Kong, SAR, China.
Zihang ChenDepartment of Psychology, The University of Hong Kong, Hong Kong, SAR, China.
Kwok-Fai SoDepartment of Ophthalmology, School of Clinical Medicine, The University of Hong Kong, Hong Kong, SAR, China.
Yong HuDepartment of Orthopaedics and Traumatology, School of Clinical Medicine, Li Kai Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR, China.
Kin ChiuDepartment of Ophthalmology, School of Clinical Medicine, The University of Hong Kong, Hong Kong, SAR, China.ORCID 0000-0001-6581-9007

Funding

Health and Medical Research Fund, Hong Kong, China 14151281Joint Founding Project of Innovation Research Institute LHJJ24JH13Midstream Research Program for Universities MRP-092-17X
6 · The paper itself

Abstract

objectiveAlzheimer's disease (AD) is the most prevalent neurodegenerative disease with limited treatment options. This study aimed to investigate the effects of Lycium barbarum extract (LBE), a Chinese herb, on the central nervous system (CNS)-including the retina, brain, and spinal cord-in 5xFAD transgenic mice after the onset of AD.

methodsStarting at 6 months of age, 5xFAD mice received daily intragastric gavage of LBE (2 g/kg) for 2 months. At 8 months, behavioral tests were conducted to assess cognition, motor function, and visual function. These included the Morris water maze, novel object recognition, and Y-maze tests for cognition; the beam walking balance and clasping tests for motor function; and electroretinogram (ERG) for visual function. Immunohistochemistry, western blotting, and ELISA were used to evaluate Aβ deposition, microglial morphology, neuroinflammation, and neuroprotective signaling pathways. Primary microglia and the IMG cell line were used to study LBE's effects on Aβ uptake and degradation in vitro.

resultsAfter 2 months of LBE treatment, the decline in cognition, motor, and visual functions in 5xFAD mice was significantly slowed. Microglia in the brain, spinal cord, and retina exhibited a neuroprotective state, with reduced Aβ deposition, decreased inflammatory cytokine levels (e.g., TNF-α, IL-1β, IL-6), increased Arg-1/iNOS ratio, and enhanced phagocytic capacity. LBE also promoted Aβ uptake and degradation in primary microglia and the IMG cell line. Neuroprotective signals such as p-Akt, p-Erk1/2, and p-CREB were elevated. Additionally, LBE treatment restored synaptic protein expression and enhanced neuroplasticity.

conclusionThe findings suggest that LBE treatment can enhance neuroplasticity, reduce systemic inflammation, and improve phagocyte clearance of Aβ deposition via inducing a neuroprotective microglial phenotype throughout CNS. As an upper-class Chinese medicine, appropriate intake of LBE may serve as a beneficial antiaging strategy for AD.

Indexed as

Alzheimer DiseaseLyciumMice, TransgenicMicrogliaNeuronal PlasticityRecovery of FunctionAmyloid beta-PeptidesAnimalsBrainCentral Nervous SystemMaleMaze LearningMicePlant ExtractsPresenilin-1Amyloid beta-PeptidesPlant ExtractsPresenilin-15xFAD miceAlzheimer's pathologycentral nervous systemLycium barbarum extractneuroinflammationneuroprotective microglial phenotyperetinaspinal cord

Identifiers

PMID39564756
PMCPMC11576918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.